Johnson & Johnson (BVC:JNJ)

Market Cap	1,968.64T
Revenue (ttm)	360.28T
Net Income (ttm)	98.21T
Shares Out	n/a
EPS (ttm)	40,458.24
PE Ratio	20.05
Forward PE	19.44
Dividend	20,693.85 (2.60%)
Ex-Dividend Date	Nov 25, 2025

Volume	14
Average Volume	15
Open	n/a
Previous Close	796,600
Day's Range	n/a
52-Week Range	594,047 - 796,600
Beta	n/a
RSI	78.81
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Colombia Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD